Skip to main content

Tech Council of Maryland - Q&A with CEO Dan Abdun-Nabi

July 25, 2015

Maryland’s biotechnology industry got another major boost this week with news that TCM member and Gaithersburg-based Emergent BioSolutions won an almost $20 million contract from the Biomedical Advanced Research and Development Authority (BARDA) to develop and manufacture a new drug to treat Ebola.  

Emergent is an active TCM member, so we decided to turn our blog over today to the company’s president and CEO, Dan Abdun-Nabi, to tell us exactly what this means for Maryland’s tech community.  Enjoy our Q&A discussion...

Read More